Page last updated: 2024-11-11

n-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide: a KCC2 cotransporter antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7211972
CHEMBL ID1491962
CHEBI ID92476
SCHEMBL ID20240442
MeSH IDM0573736

Synonyms (32)

Synonym
VU0240551-2-D4 ,
n-(4-methyl-1,3-thiazol-2-yl)-2-[(6-phenylpyridazin-3-yl)thio]acetamide
smr000310414
MLS000621247
VU0240551-1 ,
AKOS002047858
n-(4-methyl-1,3-thiazol-2-yl)-2-(6-phenylpyridazin-3-yl)sulfanylacetamide
vu0240551
893990-34-6
n-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]-acetamide
CHEMBL1491962
gtpl4665
n-(4-methyl-1,3-thiazol-2-yl)-2-[(6-phenylpyridazin-3-yl)sulfanyl]acetamide
CS-3219
HY-16689
vu 0240551
n-(4-methylthiazol-2-yl)-2-[(6-phenylpyridazin-3-yl)thio]acetamide
bdbm43891
n-(4-methyl-1,3-thiazol-2-yl)-2-(6-phenylpyridazin-3-yl)sulfanyl-ethanamide
cid_7211972
n-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide
DTXSID80428420
n-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide
CHEBI:92476
vu0240551, >=98% (hplc)
A917213
vu-0240551
n-(4-methylthiazol-2-yl)-2-((6-phenylpyridazin-3-yl)thio)acetamide
Q27089177
SCHEMBL20240442
SB19238
F85048
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyridazines
ring assemblyTwo or more cyclic systems (single rings or fused systems) which are directly joined to each other by double or single bonds are named ring assemblies when the number of such direct ring junctions is one less than the number of cyclic systems involved.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency19.95265.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency30.13130.007215.758889.3584AID588342
glp-1 receptor, partialHomo sapiens (human)Potency19.95260.01846.806014.1254AID624417
TDP1 proteinHomo sapiens (human)Potency21.83690.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency19.95260.180013.557439.8107AID1460
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency35.48133.548119.542744.6684AID743266
mitogen-activated protein kinase 1Homo sapiens (human)Potency22.38720.039816.784239.8107AID1454
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency70.79466.309660.2008112.2020AID720709
Glycoprotein hormones alpha chainHomo sapiens (human)Potency28.18384.46688.344810.0000AID624291
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
electroneutral potassium-chloride cotransporter KCC2Homo sapiens (human)IC50 (µMol)0.56000.56000.56000.5600AID1734
solute carrier family 12 member 2 isoform 1Homo sapiens (human)IC50 (µMol)0.56000.56000.56000.5600AID1734
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)0.56800.00011.774010.0000AID670901
Cytochrome P450 2C9 Homo sapiens (human)IC50 (µMol)0.56800.00002.800510.0000AID670901
Solute carrier family 12 member 2Homo sapiens (human)IC50 (µMol)50.00000.80000.80000.8000AID670921
Solute carrier family 12 member 5Homo sapiens (human)IC50 (µMol)0.56800.56800.56800.5680AID670901
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Hsf1 proteinMus musculus (house mouse)EC50 (µMol)195.00000.160024.4900236.5000AID2382
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (99)

Processvia Protein(s)Taxonomy
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
G protein-coupled receptor signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell population proliferationGlycoprotein hormones alpha chainHomo sapiens (human)
hormone-mediated signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
regulation of signaling receptor activityGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of steroid biosynthetic processGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell migrationGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid gland developmentGlycoprotein hormones alpha chainHomo sapiens (human)
luteinizing hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlycoprotein hormones alpha chainHomo sapiens (human)
negative regulation of organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid hormone generationGlycoprotein hormones alpha chainHomo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
cell volume homeostasisSolute carrier family 12 member 2Homo sapiens (human)
maintenance of blood-brain barrierSolute carrier family 12 member 2Homo sapiens (human)
intracellular sodium ion homeostasisSolute carrier family 12 member 2Homo sapiens (human)
cell volume homeostasisSolute carrier family 12 member 2Homo sapiens (human)
gamma-aminobutyric acid signaling pathwaySolute carrier family 12 member 2Homo sapiens (human)
intracellular potassium ion homeostasisSolute carrier family 12 member 2Homo sapiens (human)
intracellular chloride ion homeostasisSolute carrier family 12 member 2Homo sapiens (human)
maintenance of blood-brain barrierSolute carrier family 12 member 2Homo sapiens (human)
negative regulation of vascular wound healingSolute carrier family 12 member 2Homo sapiens (human)
regulation of spontaneous synaptic transmissionSolute carrier family 12 member 2Homo sapiens (human)
positive regulation of aspartate secretionSolute carrier family 12 member 2Homo sapiens (human)
regulation of matrix metallopeptidase secretionSolute carrier family 12 member 2Homo sapiens (human)
monoatomic ion transportSolute carrier family 12 member 2Homo sapiens (human)
cell volume homeostasisSolute carrier family 12 member 2Homo sapiens (human)
hyperosmotic responseSolute carrier family 12 member 2Homo sapiens (human)
T cell chemotaxisSolute carrier family 12 member 2Homo sapiens (human)
transepithelial chloride transportSolute carrier family 12 member 2Homo sapiens (human)
cellular response to potassium ionSolute carrier family 12 member 2Homo sapiens (human)
positive regulation of cell volumeSolute carrier family 12 member 2Homo sapiens (human)
transepithelial ammonium transportSolute carrier family 12 member 2Homo sapiens (human)
ammonium transmembrane transportSolute carrier family 12 member 2Homo sapiens (human)
inorganic anion import across plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
inorganic cation import across plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
sodium ion import across plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 12 member 2Homo sapiens (human)
chloride transmembrane transportSolute carrier family 12 member 2Homo sapiens (human)
potassium ion import across plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
cellular response to chemokineSolute carrier family 12 member 2Homo sapiens (human)
sodium ion homeostasisSolute carrier family 12 member 2Homo sapiens (human)
chloride ion homeostasisSolute carrier family 12 member 2Homo sapiens (human)
sodium ion transmembrane transportSolute carrier family 12 member 2Homo sapiens (human)
potassium ion homeostasisSolute carrier family 12 member 2Homo sapiens (human)
monoatomic ion transportSolute carrier family 12 member 5Homo sapiens (human)
hypotonic responseSolute carrier family 12 member 5Homo sapiens (human)
learningSolute carrier family 12 member 5Homo sapiens (human)
response to xenobiotic stimulusSolute carrier family 12 member 5Homo sapiens (human)
intracellular chloride ion homeostasisSolute carrier family 12 member 5Homo sapiens (human)
multicellular organism growthSolute carrier family 12 member 5Homo sapiens (human)
thermosensory behaviorSolute carrier family 12 member 5Homo sapiens (human)
intracellular pH reductionSolute carrier family 12 member 5Homo sapiens (human)
dendritic spine developmentSolute carrier family 12 member 5Homo sapiens (human)
ammonium transmembrane transportSolute carrier family 12 member 5Homo sapiens (human)
chloride transmembrane transportSolute carrier family 12 member 5Homo sapiens (human)
cell volume homeostasisSolute carrier family 12 member 5Homo sapiens (human)
chloride ion homeostasisSolute carrier family 12 member 5Homo sapiens (human)
potassium ion import across plasma membraneSolute carrier family 12 member 5Homo sapiens (human)
potassium ion homeostasisSolute carrier family 12 member 5Homo sapiens (human)
chemical synaptic transmissionSolute carrier family 12 member 5Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (37)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
protein bindingGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
protein bindingSolute carrier family 12 member 2Homo sapiens (human)
sodium:potassium:chloride symporter activitySolute carrier family 12 member 2Homo sapiens (human)
ammonium transmembrane transporter activitySolute carrier family 12 member 2Homo sapiens (human)
potassium ion transmembrane transporter activitySolute carrier family 12 member 2Homo sapiens (human)
chloride:monoatomic cation symporter activitySolute carrier family 12 member 2Homo sapiens (human)
protein kinase bindingSolute carrier family 12 member 2Homo sapiens (human)
metal ion transmembrane transporter activitySolute carrier family 12 member 2Homo sapiens (human)
protein-folding chaperone bindingSolute carrier family 12 member 2Homo sapiens (human)
Hsp90 protein bindingSolute carrier family 12 member 2Homo sapiens (human)
ammonium transmembrane transporter activitySolute carrier family 12 member 5Homo sapiens (human)
chloride transmembrane transporter activitySolute carrier family 12 member 5Homo sapiens (human)
potassium:chloride symporter activitySolute carrier family 12 member 5Homo sapiens (human)
metal ion bindingSolute carrier family 12 member 5Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (32)

Processvia Protein(s)Taxonomy
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular regionGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
Golgi lumenGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone complexGlycoprotein hormones alpha chainHomo sapiens (human)
pituitary gonadotropin complexGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
basolateral plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
basal plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
membraneSolute carrier family 12 member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
lateral plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
cytoplasmic vesicle membraneSolute carrier family 12 member 2Homo sapiens (human)
cell projection membraneSolute carrier family 12 member 2Homo sapiens (human)
cell projectionSolute carrier family 12 member 2Homo sapiens (human)
neuron projectionSolute carrier family 12 member 2Homo sapiens (human)
neuronal cell bodySolute carrier family 12 member 2Homo sapiens (human)
cell bodySolute carrier family 12 member 2Homo sapiens (human)
cell body membraneSolute carrier family 12 member 2Homo sapiens (human)
extracellular exosomeSolute carrier family 12 member 2Homo sapiens (human)
cell peripherySolute carrier family 12 member 2Homo sapiens (human)
extracellular vesicleSolute carrier family 12 member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 12 member 2Homo sapiens (human)
plasma membraneSolute carrier family 12 member 5Homo sapiens (human)
membraneSolute carrier family 12 member 5Homo sapiens (human)
dendrite membraneSolute carrier family 12 member 5Homo sapiens (human)
neuron projectionSolute carrier family 12 member 5Homo sapiens (human)
neuronal cell bodySolute carrier family 12 member 5Homo sapiens (human)
perikaryonSolute carrier family 12 member 5Homo sapiens (human)
synapseSolute carrier family 12 member 5Homo sapiens (human)
cell peripherySolute carrier family 12 member 5Homo sapiens (human)
plasma membraneSolute carrier family 12 member 5Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID670918Inhibition of human Erg at 10 uM2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.
AID670901Antagonist activity at KCC2 expressed in human HEK293 cells assessed as decrease in Tl-stimulated fluorescence increase after 8 mins by fluorescence analysis2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.
AID670917Selectivity ratio of IC50 for NKKC1 to IC50 for KCC22012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.
AID670921Antagonist activity at NKKC1 expressed in human HEK293 cells assessed as [86Rb] uptake after 30 mins by scintillation counting2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.
AID670919Inhibition of L-type calcium channel at 10 uM2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1346948Human K-Cl cotransporter 2 (SLC12 family of cation-coupled chloride transporters)2009Proceedings of the National Academy of Sciences of the United States of America, Mar-31, Volume: 106, Issue:13
Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (10.00)29.6817
2010's15 (75.00)24.3611
2020's3 (15.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.82 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]